D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$625M |
| 3 |
Merck
MRK
|
$498M |
| 4 |
Bank of America
BAC
|
$487M |
| 5 |
Fortinet
FTNT
|
$321M |
Top Sells
| 1 |
Tesla
TSLA
|
$696M |
| 2 |
Adobe
ADBE
|
$610M |
| 3 |
Accenture
ACN
|
$518M |
| 4 |
Microsoft
MSFT
|
$495M |
| 5 |
Broadcom
AVGO
|
$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
AstraZeneca
AZN
$254B
| $124M | 0.11% |
1,591,455
+1,558,105
| +4,672% | +$121M |
|
127
AbbVie
ABBV
$376B
| $124M | 0.11% |
626,907
-291,724
| -32% | -$57.6M |
|
128
AST SpaceMobile
ASTS
$11.3B
| $122M | 0.11% |
4,683,833
+4,012,372
| +598% | +$105M |
|
129
American Express
AXP
$230B
| $121M | 0.1% |
445,179
-378,142
| -46% | -$103M |
|
130
Cinemark Holdings
CNK
$2.92B
| $121M | 0.1% |
4,332,535
+1,758,767
| +68% | +$49M |
|
131
Pinduoduo
PDD
$176B
| $119M | 0.1% |
883,973
+874,386
| +9,121% | +$118M |
|
132
Twilio
TWLO
$16.3B
| $119M | 0.1% |
1,823,483
-92,361
| -5% | -$6.02M |
|
133
Five Below
FIVE
$8.43B
| $117M | 0.1% |
1,323,292
+1,276,283
| +2,715% | +$113M |
|
134
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $115M | 0.1% |
+1,429,800
| New | +$115M |
|
135
Costco
COST
$424B
| $113M | 0.1% |
127,184
-56,102
| -31% | -$49.7M |
|
136
Foot Locker
FL
$2.3B
| $112M | 0.1% |
4,353,533
+790,781
| +22% | +$20.4M |
|
137
Nucor
NUE
$33.3B
| $112M | 0.1% |
747,192
+430,568
| +136% | +$64.7M |
|
138
Liberty Media Series C
FWONK
$24.9B
| $112M | 0.1% |
1,449,719
+131,572
| +10% | +$10.2M |
|
139
Dollar Tree
DLTR
$20.4B
| $112M | 0.1% |
1,589,183
+890,452
| +127% | +$62.6M |
|
140
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $110M | 0.09% |
2,086,600
+1,989,500
| +2,049% | +$105M |
|
141
Novo Nordisk
NVO
$249B
| $108M | 0.09% |
905,585
+858,885
| +1,839% | +$102M |
|
142
BellRing Brands
BRBR
$5.38B
| $107M | 0.09% |
1,756,680
+282,740
| +19% | +$17.2M |
|
143
Arista Networks
ANET
$177B
| $106M | 0.09% |
1,107,020
+1,055,356
| +2,043% | +$101M |
|
144
ADMA Biologics
ADMA
$4.04B
| $105M | 0.09% |
5,264,095
-1,560,422
| -23% | -$31.2M |
|
145
Liberty Broadband Class C
LBRDK
$8.53B
| $105M | 0.09% |
1,353,948
-503,504
| -27% | -$38.9M |
|
146
GE Aerospace
GE
$299B
| $104M | 0.09% |
551,172
+324,144
| +143% | +$61.1M |
|
147
Home Depot
HD
$410B
| $103M | 0.09% |
254,136
-59,260
| -19% | -$24M |
|
148
Norfolk Southern
NSC
$62.8B
| $102M | 0.09% |
408,801
+270,129
| +195% | +$67.1M |
|
149
TSMC
TSM
$1.22T
| $100M | 0.09% |
576,119
+477,733
| +486% | +$83M |
|
150
Cardinal Health
CAH
$35.7B
| $99.7M | 0.09% |
902,314
+588,388
| +187% | +$65M |
|